DRYVAX
DryVax is a technology that allows the manufacture of vaccines that have aluminum-containing adjuvants into a dosage form that is not sensitive to freezing, intentionally or unintentionally. This technology can have a profound impact on the existing vaccine supply-chain because cold-chain storage accounts for up to 80% of the financial cost of vaccination, and an estimated 75-100% of the vaccine shipments are exposed to freezing temperatures resulting in costly waste and the loss of nearly half of all global vaccine supplies. This technology will also open markets that lack cold-chain storage and as a result were unreachable for broad vaccine distribution.
DRYVAX
Industry:
Information Technology Manufacturing Medical
Address:
Austin, Texas, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Zephyr Technology
Zephyr Technology is a manufacturer of heart rate monitors, remote physiological monitoring and wireless tele-health systems.
Investors List
Texas Venture Labs
Texas Venture Labs investment in Non Equity Assistance - Dryvax
More informations about "Dryvax"
Smallpox Vaccine Supply & Strength | NIAID: National Institute of ...
Sep 26, 2019 These findings helped expand the number of individuals Dryvax could protect until sufficient doses of Acam2000 were made for the entire U.S. population. People with weakened โฆSee details»
Smallpox | FDA - U.S. Food and Drug Administration
Dryvax, a smallpox vaccine, originally licensed in 1944 to Wyeth Laboratories, Inc. of Madison, N.J., was manufactured until the mid 1980s when the World Health Organization declared that โฆSee details»
Smallpox vaccine - Wikipedia
The smallpox vaccine is used to prevent smallpox infection caused by the variola virus. It is the first vaccine to have been developed against a contagious disease. In 1796, British physician Edward Jenner demonstrated that an infection with the relatively mild cowpox virus conferred immunity against the deadly smallpox virus. Cowpox served as a natural vaccine until the modern smallpoโฆSee details»
Dryvax - Crunchbase Company Profile & Funding
DryVax is a technology that allows the manufacture of vaccines that have aluminum-containing adjuvants into a dosage form that is not sensitive to freezing, intentionally or unintentionally. โฆSee details»
Smallpox and mpox vaccines: Canadian Immunization Guide
It is unclear whether these events were adverse outcomes following first-generation vaccination. The first-generation vaccine (Dryvax, Wyeth Laboratories) containing the New York City Board of Health strain of vaccinia was used in this program. VIG is available to treat certain first- and second-generation vaccine-associated adverse events.See details»
ACAM2000 (Smallpox Vaccine) Questions and Answers | FDA
Aug 19, 2022 Following a global eradication campaign, which included vaccination, the World Health Organization certified the eradication of naturally occurring smallpox disease in 1980. โฆSee details»
Smallpox vaccines: Past, present, and future - PMC
MVA has an excellent safety profile and could be used in groups in whom Dryvax is currently contraindicated. 23 MVA was given to 120,000 people in Germany in the 1970s, followed by โฆSee details»
CDC retires one old smallpox vaccine, keeps another | CIDRAP
Mar 7, 2008 In addition to the DoD program, Dryvax was used in an HHS campaign in 2003 that aimed to vaccinate 450,000 healthcare workers because of the perceived threat of a biological โฆSee details»
Long-time smallpox vaccine is destroyed - NBC News
Mar 1, 2008 Dryvax was created in the late 1800s, by the company that became Wyeth Laboratories. Wyeth was a primary U.S. manufacturer of smallpox vaccine by the mid-1940s, โฆSee details»
Vaccinia (Smallpox) Vaccine - Centers for Disease Control and โฆ
Dryvax, ® the vaccinia (smallpox) vaccine currently licensed in the United States, is a lyophilized, live-virus preparation of infectious vaccinia virus (Wyeth Laboratories, Inc., Marietta, โฆSee details»
Smallpox vaccines: from first to second to third generation
Jan 29, 2005 In their trial, Greenberg and colleagues randomly allocated 350 healthy adults to receive cell-cultured smallpox vaccine (CCSV) or calf-lymph-derived vaccine (Dryvax). โฆSee details»
Dryvax - Funding, Financials, Valuation & Investors - Crunchbase
DryVax is a technology that allows the manufacture of vaccines that have aluminum-containing adjuvants into a dosage form. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
Smallpox Vaccines for Biodefense - PMC
Current Vaccines. First generation vaccines developed during the eradication effort consist of live vaccinia virus (See Table 2).Dryvax®, the vaccine used in the US is based on the New York โฆSee details»
DryVax 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for DryVax. Use the PitchBook Platform to explore the full profile.See details»
FDA licenses repackaged smallpox vaccine from federal stockpile
The Dryvax stockpile contains about 15.4 million doses. The FDA action reduces the paperwork necessary for use of the vaccine because it will no longer be considered an investigational โฆSee details»
Human Antibody Responses to the Polyclonal Dryvax Vaccine for โฆ
The 14 Dryvax sequences consisted of 11 different plaque-purified clones (GenBank accession no. JN654977 to JN654986) isolated from a stored vial of Dryvax vaccine (lot 1556-14), two โฆSee details»
Notice to Readers: Newly Licensed Smallpox Vaccine to Replace โฆ
ACAM2000 will be replacing Dryvax ® smallpox vaccine (Wyeth Pharmaceuticals, Inc., Marietta, Pennsylvania) because of withdrawal of the Dryvax license. ACAM2000 is a live vaccinia virus derived from plaque purification cloning from Dryvax. The safety data available from the ACAM2000 clinical trials indicate a similar safety profile to Dryvax.See details»
DryVax - Headquarter Location, Corporate Office Address and โฆ
DryVax is Other Healthcare Services business from United States that founded in - ( years old in ), DryVax business is focusing on Developer. Where is DryVax headquarter and corporate โฆSee details»
Dryvax - RxChat
Welcome to the Dryvax information hub. Featuring active ingredients, dosages, related medications, and Dryvax forums. ... From 1958 to 1977, the World Health Organization โฆSee details»
New Smallpox Vaccines for an Ancient Scourge - PMC
For Dryvax and ACAM2000, respectively, the cytotoxic T lymphocyte (CTL) median lytic units were 12.5 and 15.95; the median number of spot forming units by ELISPOT per 10 6 โฆSee details»